110 related articles for article (PubMed ID: 9154310)
1. Relevance of chromatin features in the progression of esophageal epithelial severe dysplasia.
Gao F; Jütting U; Rodenacker K; Gais P; Lin PZ
Anal Cell Pathol; 1997; 13(1):17-28. PubMed ID: 9154310
[TBL] [Abstract][Full Text] [Related]
2. Discrimination of esophageal dysplasia with progression and nonprogression. High-resolution image analysis for surrogate end point biomarkers.
Zhou B; Jütting U; Rodenacker K; Gais P; Lin PZ
Anal Quant Cytol Histol; 1998 Dec; 20(6):500-8. PubMed ID: 9870102
[TBL] [Abstract][Full Text] [Related]
3. [Prediction of the outcome of dysplasia of esophageal epithelium by high resolution image analysis].
Zhou B; Ding Z; Guo L
Zhonghua Zhong Liu Za Zhi; 1999 Nov; 21(6):439-43. PubMed ID: 11776621
[TBL] [Abstract][Full Text] [Related]
4. Squamous esophageal histology and subsequent risk of squamous cell carcinoma of the esophagus. A prospective follow-up study from Linxian, China.
Dawsey SM; Lewin KJ; Wang GQ; Liu FS; Nieberg RK; Yu Y; Li JY; Blot WJ; Li B; Taylor PR
Cancer; 1994 Sep; 74(6):1686-92. PubMed ID: 8082069
[TBL] [Abstract][Full Text] [Related]
5. Epithelial repair versus carcinoma in esophageal brush cytology.
Hoover L; Berman JJ
Diagn Cytopathol; 1988; 4(3):217-23. PubMed ID: 3076105
[TBL] [Abstract][Full Text] [Related]
6. Cytological screening and 15 years' follow-up (1986-2001) for early esophageal squamous cell carcinoma and precancerous lesions in a high-risk population in Anyang County, Henan Province, Northern China.
Wang LD; Yang HH; Fan ZM; Lü XD; Wang JK; Liu XL; Sun Z; Jiang YN; He X; Zhou Q
Cancer Detect Prev; 2005; 29(4):317-22. PubMed ID: 16118042
[TBL] [Abstract][Full Text] [Related]
7. Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study.
Montgomery E; Goldblum JR; Greenson JK; Haber MM; Lamps LW; Lauwers GY; Lazenby AJ; Lewin DN; Robert ME; Washington K; Zahurak ML; Hart J
Hum Pathol; 2001 Apr; 32(4):379-88. PubMed ID: 11331954
[TBL] [Abstract][Full Text] [Related]
8. Follow-up on the gamma-glutamyl transpeptidase in patients with severe dysplasia in an area of high incidence of esophageal cancer.
Li J; Bai JX; Zhao ZG; Zheng PY; Ma J; Guo M; Liu YY
Chin J Dig Dis; 2005; 6(3):133-6. PubMed ID: 16045603
[TBL] [Abstract][Full Text] [Related]
9. Risk for esophageal neoplasia in Barrett's esophagus patients with mucosal changes indefinite for dysplasia.
Horvath B; Singh P; Xie H; Thota PN; Allende DS; Pai RK; Patil DT; Plesec TP; Goldblum JR; Liu X
J Gastroenterol Hepatol; 2015 Feb; 30(2):262-7. PubMed ID: 25087917
[TBL] [Abstract][Full Text] [Related]
10. [Quantitative study on esophageal cytology. I. Quantitative morphologic studies of normal, dysplastic and malignant squamous cells].
Xiang YV
Zhonghua Zhong Liu Za Zhi; 1990 Mar; 12(2):92-4. PubMed ID: 2401184
[TBL] [Abstract][Full Text] [Related]
11. Cytologic screening for esophageal cancer in a high-risk population in Anyang County, China.
Yang H; Berner A; Mei Q; Giercksky KE; Warloe T; Yang G; Cui J; Suo Z; Zhang S; Nesland JM
Acta Cytol; 2002; 46(3):445-52. PubMed ID: 12040635
[TBL] [Abstract][Full Text] [Related]
12. Studies on medicamentous inhibitory therapy for esophageal precancerous lesions--3- and 5-year inhibitory effects of antitumor-B, retinamide and riboflavin.
Lin P; Zhang J; Rong Z; Han R; Xu S; Gao R; Ding Z; Wang J; Feng H; Cao S
Proc Chin Acad Med Sci Peking Union Med Coll; 1990; 5(3):121-9. PubMed ID: 2098764
[TBL] [Abstract][Full Text] [Related]
13. Etiology and chemoprevention of esophageal squamous cell carcinoma.
Stoner GD; Gupta A
Carcinogenesis; 2001 Nov; 22(11):1737-46. PubMed ID: 11698334
[TBL] [Abstract][Full Text] [Related]
14. Field population-based blocking treatment of esophageal epithelia dysplasia.
Hou J; Lin PZ; Chen ZF; Ding ZW; Li SS; Men FS; Guo LP; He YT; Qiao CY; Guo CL; Duan JP; Wen DG
World J Gastroenterol; 2002 Jun; 8(3):418-22. PubMed ID: 12046061
[TBL] [Abstract][Full Text] [Related]
15. [The nuclear morphometric analysis and its clinical value in esophageal cancer].
Wang J; Chen HY; Li YM
Zhonghua Wai Ke Za Zhi; 1994 Feb; 32(2):108-10. PubMed ID: 7924661
[TBL] [Abstract][Full Text] [Related]
16. [Secondary prevention of esophageal cancer--intervention on precancerous lesions of the esophagus].
Lin PZ; Zhang JS; Cao SG; Rong ZP; Gao RQ; Han R; Shu SP
Zhonghua Zhong Liu Za Zhi; 1988 May; 10(3):161-6. PubMed ID: 3219974
[TBL] [Abstract][Full Text] [Related]
17. [Chemoprevention of esophageal cancer].
Lin P; Chen Z; Hou J; Liu T; Wang J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Dec; 20(6):413-8. PubMed ID: 11717931
[TBL] [Abstract][Full Text] [Related]
18. Natural history and significance of esophageal squamous cell dysplasia.
Jacob P; Kahrilas PJ; Desai T; Hidvegi D; Walloch J; Yokoo H; Gurley AM; Ostrow JD
Cancer; 1990 Jun; 65(12):2731-9. PubMed ID: 1692760
[TBL] [Abstract][Full Text] [Related]
19. [Medicamentous inhibitory therapy of precancerous lesions of the esophagus--3 and 5 year inhibitory effect of antitumor B, retinamide and riboflavin].
Lin P
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1990 Aug; 12(4):235-45. PubMed ID: 2147582
[TBL] [Abstract][Full Text] [Related]
20. [Long-term effect of treating patients with precancerous lesions of the esophagus].
Ding Z; Gao F; Lin P
Zhonghua Zhong Liu Za Zhi; 1999 Jul; 21(4):275-7. PubMed ID: 11776814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
